Chuang Lu is a seasoned professional in drug metabolism and pharmacokinetics, currently serving as Senior Director of DMPK/Clin Pharm at BridgeBio since September 2024. Previously, Chuang held the position of Senior Director of DMPK at Accent Therapeutics, Inc. from April 2021 to September 2024, and served as Director of Drug Metabolism at Sanofi from January 2017 to March 2021. Chuang's earlier roles include Scientific Fellow at Biogen from July 2015 to October 2016 and at Millennium Pharmaceuticals from October 2000 to July 2015. Chuang obtained a PhD in Environmental Chemistry and Chemical Toxicity from The American University in Washington DC (1985-1992) and a BS in Environmental Chemistry from Peking University (1978-1982).
This person is not in any teams
This person is not in any offices